CME Group Stock Forecast, Price & News

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 1 sell rating, 8 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CME Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares.
View analyst ratings for CME Group or view top-rated stocks.

16 Wall Street research analysts have issued 1-year target prices for CME Group's shares. Their CME stock forecasts range from $201.00 to $280.00. On average, they predict CME Group's share price to reach $246.73 in the next twelve months. This suggests a possible upside of 19.0% from the stock's current price.
View analysts' price targets for CME Group or view top-rated stocks among Wall Street analysts.

CME Group's stock was trading at $228.46 at the beginning of 2022. Since then, CME stock has decreased by 9.2% and is now trading at $207.33.
View the best growth stocks for 2022 here.

CME Group is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022.
View our earnings forecast for CME Group.

CME Group will be holding an earnings conference call on Wednesday, July 27th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

CME Group Inc. (NASDAQ:CME) released its earnings results on Wednesday, April, 27th. The financial services provider reported $2.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.00 by $0.11. The financial services provider had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. CME Group had a trailing twelve-month return on equity of 9.29% and a net margin of 57.98%. CME Group's revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.79 earnings per share.
View CME Group's earnings history.

CME Group declared a quarterly dividend on Wednesday, May 4th. Stockholders of record on Friday, June 10th will be given a dividend of $1.00 per share on Monday, June 27th. This represents a $4.00 dividend on an annualized basis and a yield of 1.93%. The ex-dividend date is Thursday, June 9th.
View CME Group's dividend history.

CME Group(NASDAQ:CME) pays an annual dividend of $4.00 per share and currently has a dividend yield of 1.91%. CME Group has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of CME Group is 52.22%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME Group will have a dividend payout ratio of 47.73% next year. This indicates that CME Group will be able to sustain or increase its dividend.
View CME Group's dividend history.

144 employees have rated CME Group CEO Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among CME Group's employees.

Some companies that are related to CME Group include Intercontinental Exchange (ICE), Moody's (MCO), MSCI (MSCI), Nasdaq (NDAQ), Interactive Brokers Group (IBKR), MarketAxess (MKTX), Arrow Financial (AROW) and California First Leasing (CFNB).
View all of CME's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), Walt Disney (DIS), Visa (V), Netflix (NFLX), Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group's stock is owned by many different institutional and retail investors. Top institutional shareholders include Capital World Investors (9.20%), Vanguard Group Inc. (8.86%), BlackRock Inc. (6.75%), State Street Corp (4.67%), Capital International Investors (3.98%) and Edgewood Management LLC (2.60%). Company insiders that own CME Group stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends for CME Group.

CME stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, Edgewood Management LLC, Parnassus Investments LLC, Sarasin & Partners LLP, Healthcare of Ontario Pension Plan Trust Fund, Bank of New York Mellon Corp, Fiera Capital Corp, and Caisse DE Depot ET Placement DU Quebec. Company insiders that have sold CME Group company stock in the last two years include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Sean Tully, Sunil Cutinho, Terrence A Duffy, and Timothy S Bitsberger.
View insider buying and selling activity for CME Group or view top insider-selling stocks.

CME stock was bought by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Capital International Investors, TD Asset Management Inc., Lord Abbett & CO. LLC, Vanguard Group Inc., Ensign Peak Advisors Inc, Invesco Ltd., and Primecap Management Co. CA.
View insider buying and selling activity for CME Group or or view top insider-buying stocks.

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CME stock can currently be purchased for approximately $207.33.

CME Group (NASDAQ:CME) has a market capitalization of $74.52 billion and generates $4.69 billion in revenue each year. The financial services provider earns $2.64 billion in net income (profit) each year or $7.659990 on an earnings per share basis.

CME Group employs 3,480 workers across the globe.

CME Group was founded in 1848.

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The official website for CME Group is www.cmegroup.com. The financial services provider can be reached via phone at (312) 930-1000, via email at [email protected], or via fax at 312-466-4410.